As of Aug 23
| +0.0154 / +1.83%|
The 4 analysts offering 12-month price forecasts for Prima BioMed Ltd have a median target of 5.50, with a high estimate of 6.00 and a low estimate of 3.00. The median estimate represents a +541.02% increase from the last price of 0.86.
The current consensus among 4 polled investment analysts is to Buy stock in Prima BioMed Ltd. This rating has held steady since August, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.